959631-30-2

Basic information

• Product Name: methyl 1-(2,6-dichlorophenyl)-4-(propan-2-yl)-1H-pyrazole-5-carboxylate
• Synonyms: methyl 1-(2,6-dichlorophenyl)-4-(propan-2-yl)-1H-pyrazole-5-carboxylate
• CAS NO: 959631-30-2
• Molecular Weight: 313.183
• Mol File: 959631-30-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 1-(2,6-dichlorophenyl)-4-(propan-2-yl)-1H-pyrazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 1-(2,6-dichlorophenyl)-4-(propan-2-yl)-1H-pyrazole-5-carboxylate(959631-30-2)
• EPA Substance Registry System: methyl 1-(2,6-dichlorophenyl)-4-(propan-2-yl)-1H-pyrazole-5-carboxylate(959631-30-2)

Safety Data

• Hazardous Substances Data: 959631-30-2(Hazardous Substances Data)

Upstream product

• 14763-24-7 (2,6-dichlorophenyl)hydrazine 
• 816-66-0 4-methyl-2-oxopentanoic acid 
• 3682-43-7 4-methyl-2-oxo-pentanoic acid methyl ester 
• 959633-29-5 3-isopropyl-4-dimethylamino-2-oxobut-3-enoic acid ethyl ester 
• 50709-36-9 (2,6-dichlorophenyl)hydrazine monohydrochloride 

Downstream Products

• 959633-04-6 3-{4'-[2-(2,6-dichloro-phenyl)-4-isopropyl-2H-pyrazol-3-ylmethoxy]-2'-methyl-biphenyl-4-yl}-acrylic acid ethyl ester 

Relevant articles and documents

HETEROCYCLIC FXR MODULATORS

The present technology is directed to compounds of formula (I), compositions, and methods related to modulation of FXR. In particular, the present compounds and compositions may be used to treat FXR-mediated disorders and conditions, including, e.g., liver disease, hyperlipidemia, hypercholesteremia, obesity, metabolic syndrome, cardiovascular disease, gastrointestinal disease, and atherosclerosis, and renal disease.

FXR AGONISTS

Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.